Bioregenx (BRGX) Non-Current Assets (2021 - 2026)
Bioregenx (BRGX) recorded quarterly Non-Current Assets of $146778.0 in Q1 2026, down 8.1% quarter-over-quarter from $159721.0 in Q4 2025, and down 22.08% on a YoY basis from $188362.0 in Q1 2025.
Bioregenx (BRGX) Non-Current Assets (2021 - 2026) Analysis & Trends
Bioregenx's Non-Current Assets history runs 6 years deep, the most recent figure standing at $146778.0 for Q1 2026.
- In Q1 2026, Non-Current Assets fell 22.08% year-over-year to $146778.0; the TTM figure through Mar 2026 stood at $2.1 million (down 93.98% YoY), while the FY2025 annual figure was $159721.0, down 20.43% from the prior year.
- Non-Current Assets was $146778.0 for Q1 2026 at Bioregenx, down from $159721.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $18.1 million in Q1 2024 to a low of $31640.0 in Q4 2023.
- Historically, Non-Current Assets has averaged $4.0 million across 5 years, with a median of $174041.5 in 2025.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets soared 51040.25% in 2024, then slumped 98.96% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $58473.0 in 2022, then tumbled by 45.89% to $31640.0 in 2023, then soared by 534.45% to $200739.0 in 2024, then decreased by 20.43% to $159721.0 in 2025, then retreated by 8.1% to $146778.0 in 2026.
- The last three Non-Current Assets figures came in at $146778.0 (Q1 2026), $159721.0 (Q4 2025), and $894608.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 1.07 Bn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 3.52 Bn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 2.84 Bn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 188.72 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 346.03 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 179.42 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 5.45 Bn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 451.87 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 1.28 Bn |
| 10 | Bioregenx | - | - | 348,288.00 | 146,778.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 146,778.00 |
| Dec 31, 2025 | 159,721.00 |
| Sep 30, 2025 | 894,608.00 |
| Jun 30, 2025 | 900,985.00 |
| Mar 31, 2025 | 188,362.00 |
| Dec 31, 2024 | 200,739.00 |
| Sep 30, 2024 | 16.99 Mn |
| Jun 30, 2024 | 17.56 Mn |
| Mar 31, 2024 | 18.13 Mn |
| Dec 31, 2023 | 31,640.00 |
| Sep 30, 2023 | 33,223.00 |
| Jun 30, 2023 | 85,506.00 |
| Mar 31, 2023 | 77,989.00 |
| Dec 31, 2022 | 58,473.00 |
| Dec 31, 2021 | 103,404.00 |